• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnebulo Pharmaceuticals
    Picture of Anebulo Pharmaceuticals logo

    ANEB — Anebulo Pharmaceuticals News Story

    $0.290.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $11.83m
    • Enterprise Value
      $2.79m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANEB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANEB Dividends
    All News

    NASDAQ RESUMED AT 02:22 PM

    Picture of Anebulo Pharmaceuticals logoAnebulo Pharmaceuticals
    17/12/2021 19:22
    NASDAQ RESUMED  ANEB.O  AT 02:22 PM
    

    Recent news on Anebulo Pharmaceuticals

    See all news
    • Advisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn

      12/02/2026 23:12
    • Anebulo Pharmaceuticals Q2 net loss narrows

      12/02/2026 21:27
    • Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC

      06/02/2026 14:01
    • Anebulo Pharmaceuticals posts Q1 net loss

      13/11/2025 21:18
    • Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results

      29/09/2025 23:51

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.